Christian Gournay - Alterola Biotech Insider

Alterola Biotech -- USA Stock  

USD 1.25  0.30  19.35%

Deputy CEO in charge of Residential Property, Regions and Institutional Relations, Member of the Executive Committee

Mr. Christian de Gournay is Deputy Chief Executive Officer in charge of Residential Property, Regions and Institutional Relations, and a Member of the Executive Committee of Altarea SCA. He is also a Member of the Company Operation Committee, Strategy Committee and Investment Committee. He is a graduate of Hautes Etudes Commerciales amd Ecole Nationale dAdministration and started his career working for the Conseil dEtat in 1978. He then joined Banque Indosuez in 1978 and was notably Managing Director of the Swiss branches of the bank. He was subsequently appointed Deputy Managing Director of AGF in 1994 and was responsible for real estate asset management and banking and financial activities. He joined Cogedim in 2002 as Vice Chairman of the Management Board and was appointed Chairman of the Management Board in 2003.
Age: 59        

Management Efficiency

The company has return on total asset (ROA) of (133.34) % which means that it has lost $133.34 on every $100 spent on asset. This is way below average.
The company currently holds 175.75 K in liabilities with Debt to Equity (D/E) ratio of 0.67 which is about average as compared to similar companies. Alterola Biotech has Current Ratio of 0.01 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech operates under Conglomerates classification in USA and traded on OTC Market. It employs 1 people.Alterola Biotech (ALTA) is traded on OTC Market in USA. It is located in 340 South Lemon Avenue and employs 1 people.

Alterola Biotech Leadership Team

Stock Performance Indicators

Current Sentiment - ALTA

Alterola Biotech Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Alterola Biotech. What is your sentiment towards investing in Alterola Biotech? Are you bullish or bearish?
50% Bullish
50% Bearish
Skip  Hide

BATS Exchange Efficient Frontier

Diversify in USA Market
The main assumption in equity investing is that a higher degree of volatility (or risk) means a higher potential (or expected) return on investment. Conversely, investors who take on a low degree of risk have a low expection for return.
Diversify Portfolios
You can create optimal portfolios in USA market or optimize your existing portfolio in one of two ways: 1) For any level of risk, select the one which has the highest expected return. 2) For any expected return, select the one which has the lowest volatility.
Diversify Portfolios
Check also Trending Equities. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.